Overview
- Description
The company develops therapeutic molecules targeting dependence receptors and their ligands to treat various cancers, alleviating resistance to chemotherapy, targeted therapy and immunotherapy.
- Website
- Country
- France
- Sector
- Health Biotechnology
Engage with NETRIS PHARMA SAS*
*By clicking here you will be leaving the official EIC website and you will be directed to the Dealroom.co domain, an official EISMEA contractor for the EIC investor matchmaking platform.